Veru Soars 35% After FDA Approves Sabizabulin Data for Emergency Authorization
(Veru) Shares of Veru Inc. rose more than 35% in premarket on Wednesday after FDA said it was due for an emergency authorization of Sabizabulin in hospitalized COVID-19 Patients. FDA…